BMY vs. DOW
BMY (Bristol-Myers Squibb Company) and DOW (Dow Inc.) are both stocks. BMY operates in Drug Manufacturers - General (Healthcare), while DOW operates in Chemicals (Basic Materials). Over the past 5 years, BMY returned 0.73%/yr vs -8.14%/yr for DOW. At a 0.23 correlation, their price movements are largely independent.
Performance
BMY vs. DOW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMY achieves a 8.27% return, which is significantly lower than DOW's 47.99% return.
BMY
- 1D
- 0.40%
- 1M
- 0.23%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
DOW
- 1D
- 0.65%
- 1M
- -11.76%
- YTD
- 47.99%
- 6M
- 44.34%
- 1Y
- 19.13%
- 3Y*
- -8.82%
- 5Y*
- -8.14%
- 10Y*
- —
BMY vs. DOW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 32.82% |
DOW Dow Inc. | 47.99% | -37.38% | -22.79% | 14.71% | -6.65% | 6.81% | 7.88% | 8.40% |
Correlation
The correlation between BMY and DOW is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Mar 20, 2019 | 0.23 |
The correlation between BMY and DOW shifts across timeframes, from 0.11 (1 year) to 0.23 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BMY:
$116.75B
DOW:
$24.41B
BMY:
$3.57
DOW:
-$3.86
BMY:
2.40
DOW:
0.61
BMY:
5.82
DOW:
1.60
BMY:
$48.48B
DOW:
$39.33B
BMY:
$33.33B
DOW:
$2.42B
BMY:
$13.34B
DOW:
$840.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMY vs. DOW — Risk / Return Rank
BMY
DOW
BMY vs. DOW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and Dow Inc. (DOW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BMY | DOW | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.31 | ||
| Sortino ratioReturn per unit of downside risk | +0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.11 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.53 | 0.58 | +0.95 |
| Martin ratioReturn relative to average drawdown | 3.32 | 1.08 | +2.24 |
Loading charts...
Drawdowns
BMY vs. DOW - Drawdown Comparison
The maximum BMY drawdown since its inception was -72.03%, which is greater than DOW's maximum drawdown of -64.37%. Use the drawdown chart below to compare losses from any high point for BMY and DOW.
Loading charts...
Drawdown Indicators
| BMY | DOW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.03% | -64.37% | -7.66% |
Max Drawdown (1Y)Largest decline over 1 year | -12.05% | -31.73% | +19.68% |
Max Drawdown (3Y)Largest decline over 3 years | -36.85% | -62.16% | +25.31% |
Max Drawdown (5Y)Largest decline over 5 years | -47.67% | -64.37% | +16.70% |
Max Drawdown (10Y)Largest decline over 10 years | -47.67% | — | — |
Current DrawdownCurrent decline from peak | -17.79% | -39.19% | +21.40% |
Average DrawdownAverage peak-to-trough decline | -22.38% | -22.79% | +0.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.34% | 16.86% | -10.52% |
Volatility
BMY vs. DOW - Volatility Comparison
Bristol-Myers Squibb Company (BMY) and Dow Inc. (DOW) have volatilities of 8.22% and 8.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMY | DOW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.22% | 8.55% | -0.33% |
Volatility (6M)Calculated over the trailing 6-month period | 18.18% | 32.80% | -14.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.08% | 49.35% | -22.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.02% | 33.56% | -9.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.29% | 38.69% | -13.40% |
Dividends
BMY vs. DOW - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.38%, more than DOW's 4.14% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
DOW Dow Inc. | 4.14% | 8.98% | 6.98% | 5.11% | 5.56% | 4.94% | 5.05% | 3.84% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BMY vs. DOW - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and Dow Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMY vs. DOW - Profitability Comparison
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
DOW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported a gross profit of 640.00M and revenue of 9.79B. Therefore, the gross margin over that period was 6.5%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
DOW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported an operating income of -31.00M and revenue of 9.79B, resulting in an operating margin of -0.3%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
DOW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dow Inc. reported a net income of -445.00M and revenue of 9.79B, resulting in a net margin of -4.5%.
Frequently Asked Questions
BMY and DOW have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DOW has higher volatility (8.55%) compared to BMY (8.22%). In terms of maximum drawdown, BMY dropped -72.03% vs DOW's -64.37%.
BMY currently has the higher Sharpe Ratio (0.68 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMY and DOW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer